Hugo Vanderstichele

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Leslie M. Shaw, Hugo Vanderstichele, Małgorzata Knapik-Czajka et al. · Annals of Neurology · 2009 · 2.1K citations · Full text

Medicine, Neurology, Neuroscience +17

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

Bart De Strooper, Paul Säftig, Katleen Craessaerts et al. · Nature · 1998 · 1.8K citations

Life Sciences, Molecular Biology, Neuroscience +15

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Frank Hulstaert, Kaj Blennow, Adrian Ivanoiu et al. · Neurology · 1999 · 732 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

Niels Andreasen, Camilla Hesse, Pia Davidsson et al. · Archives of Neurology · 1999 · 671 citations

Life Sciences, Neurology, Neuroscience +17

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Niels Andreasen, Lennart Minthon, Pia Davidsson et al. · Archives of Neurology · 2001 · 573 citations

Medicine, Neurology, Neuroscience +17